JN BIOTECH ApS: Financial statements 2022
CVR: 25325001
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
JN BIOTECH ApS (CVR 25325001) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 82,084 and a net result of DKK 338,399 compared with DKK 1,643,481 the year before. That is a decrease of 29% compared with the year before. Equity in the 2022 report amounted to DKK 3,005,276. The solvency ratio was 82.7%.
- Gross Profit
- DKK 82,084
- Profit/Loss
- DKK 338,399
- Equity
- DKK 3,005,276
- Total Assets
- DKK 3,634,355
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 82K | 338K | 3M | 0 |
| 2021 | - | 116K | 1.6M | 15.7M | 0 |
| 2018 | - | 73K | 12.8M | 13.7M | 0 |
| 2017 | - | 81K | 103K | 872K | 0 |
| 2016 | - | 112K | 100K | 768K | - |
Official annual report
Keep an eye on JN BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout JN BIOTECH ApS
JN BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Andre personlige serviceydelser i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by JBN Biotech ApS. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK 90,325 and a net result of DKK 104,408 compared with DKK 60,995 the year before. Equity in the 2025 report amounted to DKK 821,161.